Seeing Is Believing
Currently out of the existing stock ratings of Anupam Rama, 292 are a BUY (75.45%), 70 are a HOLD (18.09%), 25 are a SELL (6.46%).
Analyst Anupam Rama, currently employed at JPMORGAN, carries an average stock price target met ratio of 44.41% that have a potential upside of 37.22% achieved within 221 days.
Anupam Rama’s has documented 750 price targets and ratings displayed on 61 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REPL, Replimune Group at 19-Sep-2025.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/22/2024. The price target of $25 was fulfilled within 3 days with a profit of $8.7 (53.37%) receiving and performance score of 177.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$56
$15.5 (38.27%)
$58
1 months 6 days ago
(03-Sep-2025)
0/2 (0%)
$19.87 (55.00%)
Buy
$51
$10.5 (25.93%)
$54
2 months 18 days ago
(21-Jul-2025)
6/9 (66.67%)
$11.34 (28.59%)
477
Hold
$43
$2.5 (6.17%)
$46
7 months 7 days ago
(02-Mar-2025)
4/5 (80%)
$9.88 (29.83%)
169
Buy
$57
$16.5 (40.74%)
$55
10 months ago
(09-Dec-2024)
5/6 (83.33%)
$10.98 (23.86%)
84
Buy
$51
$10.5 (25.93%)
1 years ago
(09-Oct-2024)
1/1 (100%)
$9.18 (21.95%)
27
Which stock is Anupam Rama is most bullish on?
Which stock is Anupam Rama is most reserved on?
What Year was the first public recommendation made by Anupam Rama?